Biological Psychiatry
Volume 64, Issue 11 , Pages 974-981 , 1 December 2008

A Novel Delta Opioid Receptor Antagonist, SoRI-9409, Produces a Selective and Long-Lasting Decrease in Ethanol Consumption in Heavy-Drinking Rats

  • Carsten K. Nielsen

      Affiliations

    • Ernest Gallo Clinic and Research Center, University of California San Francisco, Emeryville, California
    • ,
  • Jeffrey A. Simms

      Affiliations

    • Ernest Gallo Clinic and Research Center, University of California San Francisco, Emeryville, California
    • ,
  • Haley B. Pierson

      Affiliations

    • Ernest Gallo Clinic and Research Center, University of California San Francisco, Emeryville, California
    • ,
  • Rui Li

      Affiliations

    • Ernest Gallo Clinic and Research Center, University of California San Francisco, Emeryville, California
    • ,
  • Surendra K. Saini

      Affiliations

    • Organic Chemistry Department, Southern Research Institute, Birmingham, Alabama
    • ,
  • Subramaniam Ananthan

      Affiliations

    • Organic Chemistry Department, Southern Research Institute, Birmingham, Alabama
    • ,
  • Selena E. Bartlett

      Affiliations

    • Ernest Gallo Clinic and Research Center, University of California San Francisco, Emeryville, California
    • Corresponding Author InformationAddress reprint requests to Selena E. Bartlett, Ph.D., Ernest Gallo Clinic and Research Center, University of California San Francisco, 5858 Horton Street, Suite 200, Emeryville, CA, 94608

Received 5 March 2008 ,Revised 12 July 2008 ,Accepted 18 July 2008.

References 

  1. Stromberg MF, Casale M, Volpicelli L, Volpicelli JR, O'Brien CP. A comparison of the effects of the opioid antagonists naltrexone, naltrindole, and beta-funaltrexamine on ethanol consumption in the rat. Alcohol. 1998;15:281–289
  2. Altshuler HL, Phillips PE, Feinhandler DA. Alteration of ethanol self-administration by naltrexone. Life Sci. 1980;26:679–688
  3. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry. 1992;49:876–880
  4. O'Malley SS, Krishnan-Sarin S, Farren C, Sinha R, Kreek MJ. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis. Psychopharmacology (Berl). 2002;160:19–29
  5. Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: The COMBINE study: A randomized controlled trial. JAMA. 2006;295:2003–2017
  6. Oslin DW, Berrettini WH, O'Brien CP. Targeting treatments for alcohol dependence: The pharmacogenetics of naltrexone. Addict Biol. 2006;11:397–403
  7. Hollister LE, Johnson K, Boukhabza D, Gillespie HK. Aversive effects of naltrexone in subjects not dependent on opiates. Drug Alcohol Depend. 1981;8:37–41
  8. Crowley TJ, Wagner JE, Zerbe G, Macdonald M. Naltrexone-induced dysphoria in former opioid addicts. Am J Psychiatry. 1985;142:1081–1084
  9. Mitchell JE, Morley JE, Levine AS, Hatsukami D, Gannon M, Pfohl D. High-dose naltrexone therapy and dietary counseling for obesity. Biol Psychiatry. 1987;22:35–42
  10. Pfohl DN, Allen JI, Atkinson RL, Knopman DS, Malcolm RJ, Mitchell JE, et al. Naltrexone hydrochloride (Trexan): A review of serum transaminase elevations at high dosage. NIDA Res Monogr. 1986;67:66–72
  11. Lucey MR, Silverman BL, Illeperuma A, O'Brien CP. Hepatic safety of once-monthly injectable extended-release naltrexone administered to actively drinking alcoholics. Alcohol Clin Exp Res. 2008;32:498–504
  12. Ananthan S, Kezar HS, Carter RL, Saini SK, Rice KC, Wells JL, et al. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans. J Med Chem. 1999;42:3527–3538
  13. Goldstein A, Naidu A. Multiple opioid receptors: Ligand selectivity profiles and binding site signatures. Mol Pharmacol. 1989;36:265–272
  14. Roberts AJ, Gold LH, Polis I, McDonald JS, Filliol D, Kieffer BL, et al. Increased ethanol self-administration in delta-opioid receptor knockout mice. Alcohol Clin Exp Res. 2001;25:1249–1256
  15. Ingman K, Salvadori S, Lazarus L, Korpi ER, Honkanen A. Selective delta-opioid receptor antagonist N,N(CH3)2-Dmt-Tic-OH does not reduce ethanol intake in alcohol-preferring AA rats. Addict Biol. 2003;8:173–179
  16. Froehlich JC, Badia-Elder NE, Zink RW, McCullough DE, Portoghese PS. Contribution of the opioid system to alcohol aversion and alcohol drinking behavior. J Pharmacol Exp Ther. 1998;287:284–292
  17. Froehlich JC, Zweifel M, Harts J, Lumeng L, Li TK. Importance of delta opioid receptors in maintaining high alcohol drinking. Psychopharmacology (Berl). 1991;103:467–472
  18. Steensland P, Simms JA, Holgate J, Richards JK, Bartlett SE. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking. Proc Natl Acad Sci U S A. 2007;104:12518–12523
  19. Simms JA, Steensland P, Medina B, Abernathy K, Chandler LJ, Wise R, et al. Intermittent-access to 20% ethanol induces high ethanol consumption in Long-Evans and Wistar rats. Alcohol Clin Exp Res. 2008;32:1–8
  20. Wise RA. Voluntary ethanol intake in rats following exposure to ethanol on various schedules. Psychopharmacologia. 1973;29:203–210
  21. Krishnan-Sarin S, Jing SL, Kurtz DL, Zweifel M, Portoghese PS, Li TK, et al. The delta opioid receptor antagonist naltrindole attenuates both alcohol and saccharin intake in rats selectively bred for alcohol preference. Psychopharmacology (Berl). 1995;120:177–185
  22. Franck J, Lindholm S, Raaschou P. Modulation of volitional ethanol intake in the rat by central delta-opioid receptors. Alcohol Clin Exp Res. 1998;22:1185–1189
  23. Escher T, Mittleman G. Schedule-induced alcohol drinking: Non-selective effects of acamprosate and naltrexone. Addict Biol. 2006;11:55–63
  24. Myers RD, Borg S, Mossberg R. Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey. Alcohol. 1986;3:383–388
  25. Ukai M, Holtzman SG. Effects of intrahypothalamic administration of opioid peptides selective for mu-, kappa, and delta-receptors on different schedules of water intake in the rat. Brain Res. 1988;459:275–281
  26. Gardell LR, Hubbell CL, Reid LD. Naltrexone persistently reduces rats' intake of a palatable alcoholic beverage. Alcohol Clin Exp Res. 1996;20:584–588
  27. Asakawa A, Inui A, Momose K, Ueno N, Fujino MA, Kasuga M. Endomorphins have orexigenic and anxiolytic activities in mice. Neuroreport. 1998;9:2265–2267
  28. Filliol D, Ghozland S, Chluba J, Martin M, Matthes HW, Simonin F, et al. Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet. 2000;25:195–200
  29. Perrine SA, Hoshaw BA, Unterwald EM. Delta opioid receptor ligands modulate anxiety-like behaviors in the rat. Br J Pharmacol. 2006;147:864–872
  30. Oguri K, Yamada-Mori I, Shigezane J, Hirano T, Yoshimura H. Potentiation of physical dependence by conjugation at the 6-position of nalorphine. Eur J Pharmacol. 1984;102:229–235
  31. Berkowitz BA, Spector S, Lee CH. Mechanism of narcotic antagonist and narcotic antagonist analgesic action. In:  Ford DH,  Clouet DH editor. Tissues Responses to Addictive Drugs. Jamaica, New York: Spectrum Publications; 1976;p. 139–153
  32. Misra AL, Bloch R, Vardy J, Mule SJ, Verebely K. Disposition of (15,16-3H)naltrexone in the central nervous system of the rat. Drug Metab Dispos. 1976;4:276–280
  33. Wang J, Carnicella S, Phamluong K, Jeanblanc J, Ronesi JA, Chaudhri N, et al. Ethanol induces long-term facilitation of NR2B-NMDA receptor activity in the dorsal striatum: Implications for alcohol drinking behavior. J Neurosci. 2007;27:3593–3602
  34. Logrip ML, Janak PH, Ron D. Dynorphin is a downstream effector of striatal BDNF regulation of ethanol intake. FASEB J. 2008;22:2393–2404
  35. Roberts AJ, McDonald JS, Heyser CJ, Kieffer BL, Matthes HW, Koob GF, et al. mu-Opioid receptor knockout mice do not self-administer alcohol. J Pharmacol Exp Ther. 2000;293:1002–1008
  36. Hall FS, Sora I, Uhl GR. Ethanol consumption and reward are decreased in mu-opiate receptor knockout mice. Psychopharmacology (Berl). 2001;154:43–49
  37. Becker A, Grecksch G, Kraus J, Loh HH, Schroeder H, Hollt V. Rewarding effects of ethanol and cocaine in mu opioid receptor-deficient mice. Naunyn Schmiedebergs Arch Pharmacol. 2002;365:296–302
  38. Kovacs KM, Szakall I, O'Brien D, Wang R, Vinod KY, Saito M, et al. Decreased oral self-administration of alcohol in kappa-opioid receptor knock-out mice. Alcohol Clin Exp Res. 2005;29:730–738
  39. Critcher EC, Lin CI, Patel J, Myers RD. Attenuation of alcohol drinking in tetrahydroisoquinoline-treated rats by morphine and naltrexone. Pharmacol Biochem Behav. 1983;18:225–229
  40. Hyytia P, Kiianmaa K. Suppression of ethanol responding by centrally administered CTOP and naltrindole in AA and Wistar rats. Alcohol Clin Exp Res. 2001;25:25–33
  41. Ciccocioppo R, Martin-Fardon R, Weiss F. Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats. Neuropsychopharmacology. 2002;27:391–399
  42. June HL, McCane SR, Zink RW, Portoghese PS, Li TK, Froehlich JC. The delta 2-opioid receptor antagonist naltriben reduces motivated responding for ethanol. Psychopharmacology (Berl). 1999;147:81–89
  43. Krishnan-Sarin S, Portoghese PS, Li TK, Froehlich JC. The delta 2-opioid receptor antagonist naltriben selectively attenuates alcohol intake in rats bred for alcohol preference. Pharmacol Biochem Behav. 1995;52:153–159
  44. Mitchell JM, Liang MT, Fields HL. A single injection of the kappa opioid antagonist norbinaltorphimine increases ethanol consumption in rats. Psychopharmacology (Berl). 2005;182:384–392
  45. Holter SM, Henniger MS, Lipkowski AW, Spanagel R. Kappa-opioid receptors and relapse-like drinking in long-term ethanol-experienced rats. Psychopharmacology (Berl). 2000;153:93–102
  46. Reid LD, Hunter GA. Morphine and naloxone modulate intake of ethanol. Alcohol. 1984;1:33–37
  47. Lindholm S, Werme M, Brene S, Franck J. The selective kappa-opioid receptor agonist U50,488H attenuates voluntary ethanol intake in the rat. Behav Brain Res. 2001;120:137–146

PII: S0006-3223(08)00887-1

doi: 10.1016/j.biopsych.2008.07.018

Biological Psychiatry
Volume 64, Issue 11 , Pages 974-981 , 1 December 2008

Article Tools

* Image Usage & Resolution